Cleared Traditional

K161318 - Phantom Fukushima Neurological Holding Systems, Phantom Mastability Neurological Holding Systems

K161318 is an FDA 510(k) clearance for Phantom Fukushima Neurological Holding ..., manufactured by Tedan Surgical Innovations, LLC. The device is a Class 2 Neurology device with product code GZT cleared through the Traditional 510(k) pathway after a 313-day FDA review.

K161318 · Tedan Surgical Innovations, LLC · Neurology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 2017
Decision
313d
Days
Class 2
Risk

K161318 is an FDA 510(k) clearance for the Phantom Fukushima Neurological Holding Systems, Phantom Mastability Neurologi.... Classified as Retractor, Self-retaining, For Neurosurgery (product code GZT), Class II - Special Controls.

Submitted by Tedan Surgical Innovations, LLC (Sugar Land, US). The FDA issued a Cleared decision on March 20, 2017 after a review of 313 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.4800 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Elevated predicate reliance profile. This clearance follows a standard predicate-based equivalence path within the Neurology review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K161318

510(k) Number K161318 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received May 11, 2016
Decision Date March 20, 2017
Days to Decision 313 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
164d slower than avg
Panel avg: 149d · This submission: 313d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZT Device Classification - Class 2, Special Controls

Product Code GZT Retractor, Self-retaining, For Neurosurgery
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.4800
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZT Retractor, Self-retaining, For Neurosurgery

All 34
Devices cleared under the same product code (GZT) and FDA review panel - the closest regulatory comparables to K161318.
Geister retractor for neuro - and spine surgery
K180610 · Geister Medizin Technik GmbH · Aug 2018
NICO BrainPath
K172433 · Nico Corporation · Sep 2017
MEDICON Spinal Spreading Systems
K161680 · Medicon EG · Mar 2017
Self-retaining Retractor
K161004 · Fetzer Medical GmbH & Co. KG · Sep 2016
NICO BrainPath & Accessories, NICO BrainPath, NICO Shepherd's Hook
K150378 · Nico Corporation · Jun 2015
BRAIN PORT
K120691 · Nico Corporation · Jun 2012